DUKAL Corporation has announced a U.S. voluntary nationwide recall of selected lots of benzalkonium chloride swabs and antiseptic wipes manufactured for DUKAL by Jianerkang Medical Dressing Co. Benzalkonium chloride antiseptic wipes are sold separately over the counter and in kits.
This recall is being initiated due to concerns about potential microbial contamination with Burkholderia cepacia. All customers are advised to discontinue use of products identified in this recall immediately as their use could lead to infections, some of which pose certain health risks in immune-suppressed patients. For average healthy people, the presence of Burkholderia cepacia on the swab is not likely to cause serious health risks.
To date, there have been no reported incidents involving these products. In an abundance of caution, the distributor is voluntarily recalling these products to prevent any such potential risk. All customers should dispose of the product. All distributors and kit packers, who include benzalkonium chloride swabs or antiseptic wipes as a component in their kits, should discontinue use of the product and initiate a sub-recall to their customers. All distributors and kit packers should return product in their inventories to DUKAL. These products were distributed nationwide to the wholesale and retail levels.
DUKAL continues to work closely with the Food and Drug Administration (FDA) to ensure that its products meet or exceed the agency's requirements.
For a list of BZK product lot numbers from the FDA, CLICK HERE.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.